News

David Rochkind and the Pulitzer Center Capturing the Human Faces behind TB

Photo: David Rochkind

On World TB Day March 24, there will be a Congressional Briefing on multi-drug resistant TB (MDR-TB) where David Rochkind, the award winning photographer and Pulitzer Center grantee, will present his reporting and photography on his exploration into the MDR-TB crisis in Moldova. There will also be a panel discussion on the burden of TB in the US and around the globe, the role of the US in implementing the Global Plan to Stop TB and the successes and challenges in prevention, diagnosis and treatment of TB.

Mr. Rochkind began working with capturing the human faces behind this global epidemic in South Africa with the country’s gold miners. In early 2010, he traveled to Inida to observe the disease in the context of urban settings and then made his way to Moldova where the country has been hit hard by a deteriorating health system and 30% of all cases of TB are multi-drug resistant.

The Pulitzer Center on Crisis Reporting is a non-profit journalism institute based out of Washington, DC, working to highlight systematic crises around the world through high-quality journalism, photography and multimedia and provided support to Mr. Rochkind for this project “Moldova: Fighting a Deadly Disease”.

Based on the work his work, David Rochkind, along with the Pulitzer Center on Crisis Reporting and Lilly MDR-TB Partnership, created a free online education program called “EPIDEMIC: TB in the Global Community” targeting anyone who wants to learn more about TB, the challenges to communities, and possible solutions being developed. The website also offers downloadable lesson plans for high schools to integrate into their curriculum and tools to show students how to become active against TB outside of the classroom.

Slideshow of “TB in Moldova”

More News
30 Mar 2021
Médecins Sans Frontières (MSF) published a press release on World TB Day 2021 announcing their clinical trial, TB-Practecal , investigating novel treatment for MDR-TB has stopped enrolling earlier than originally planned due to promising results. The trial's independent data safety and monitoring...
3 Feb 2021
Last week, the World Health Organization (WHO) held a consultation to discuss the definition of extensively drug resistant (XDR) tuberculosis. The meeting was held to discuss novel treatment regimens and diagnostics for drug-resistant TB and determine its impact on the definition of XDR-TB. The...
10 Dec 2020
The Stop TB Partnership Working Group on New TB Vaccines (WGNV), Working Group on New TB Drugs (WGND), and New Diagnostics Working Group (NDWG) are developing an online course specifically designed for advocates and affected communities to provide a base of knowledge in TB research and to generate...